Foxx Development Holdings Inc. (FOXX): Nasdaq/NYSE listing notice — Foxx Development receives Nasdaq deficiency notice for MVLS below $35M

Foxx Development Holdings Inc.

Received deficiency letter on Nov 5, 2025 for failing to meet $35M MVLS threshold for 30 consecutive business days.
Has until May 4, 2026 to regain compliance; MVLS must close at $35M+ for 10 consecutive business days.
Company may consider available options to regain compliance but cannot assure success.
If not regained by deadline, Nasdaq staff will issue delisting notice; company may appeal.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Foxx Development Holdings Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

November 5, 2025, the Company received a deficiency letter (the “Letter”) from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for a period of 30 consecutive business days, the Company’s market value of listed securities (“MVLS”) closed below the $35,000,000 MVLS threshold required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has until May 4, 2026 to regain compliance with the MVLS Requir

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Foxx Development Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-108203

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.